Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02503631 · ClinicalTrials.gov registry record

Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract Cancers

A clinical trial, sponsored by Exact Sciences Corporation.

Terminated
Registry status
397
Enrollment target

NCT02503631 is a clinical trial that was terminated before completion, run by Exact Sciences Corporation. The registered enrollment target is 397 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02503631 was terminated before completion, sponsored by Exact Sciences Corporation.

TERMINATED
Registry status
397 participants
Enrollment target

Study Summary

The primary objective of this study is to obtain de-identified, clinically characterized, stool and plasma specimens for use in assessing new markers for the detection of neoplasms of the digestive tract.

Interventions

  • DEVICE Stool Sample Collection Kit

Trial Details

FieldValue
Enrollment Target 397 participants
Start Date 2014-10
Est. Completion 2017-09

Sponsor

Exact Sciences Corporation

30 total trials

What the Registry Record Tells You About NCT02503631

The ClinicalTrials.gov registry entry for NCT02503631 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 397 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Exact Sciences Corporation, which has 30 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Stool Sample Collection Kit is the first listed.

NCT02503631 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02503631 about?

NCT02503631 is a clinical study titled "Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract Cancers". The primary objective of this study is to obtain de-identified, clinically characterized, stool and plasma specimens for use in assessing new markers for the detection of neoplasms of the digestive tract.

What is the current status of trial NCT02503631?

This trial is currently terminated. The enrollment target is 397 participants. The study started on 2014-10. Estimated completion is 2017-09.

What interventions are being tested in trial NCT02503631?

The interventions under investigation include: Stool Sample Collection Kit (DEVICE).

Who is sponsoring clinical trial NCT02503631?

This trial is sponsored by Exact Sciences Corporation, which has 30 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.